Benzinga | Nov 12, 2021 07:26AM EST

Leap Therapeutics Q3 EPS $(0.14) Down From $(0.09) YoY

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.14) per share. This is a 55.56 percent decrease over losses of $(0.09) per share from the same period last year.